Antiproliferative effects of formononetin were also demonstrated in cytokine-induced cancer models, such as multiple myeloma, where formononetin attenuated the expression of inflammatory cytokines, including tumor necrosis factor-α (TNF-α), transforming growth factor-β1 (TGF-β1), interleukin-6 (IL-6), and interleukin-8 (IL-8) by downregulating hypoxia-inducible factor 1α (HIF-1α) [39,100] and nuclear factor-κB (NF-κB) [101]. The gene discussed is CXCL8; the disease is plasma cell myeloma.